HTG Molecular Diagnostics, Inc.

Symbol: HTGM

NASDAQ

0.48

USD

Market price today

  • -0.0745

    P/E Ratio

  • -0.0008

    PEG Ratio

  • 1.06M

    MRK Cap

  • 0.00%

    DIV Yield

HTG Molecular Diagnostics, Inc. (HTGM) Stock Price & Analysis

Shares Outstanding

2.21M

Gross Profit Margin

0.18%

Operating Profit Margin

-2.95%

Net Profit Margin

-3.02%

Return on Assets

-1.31%

Return on Equity

-6.05%

Return on Capital Employed

-3.23%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Mr. John L. Lubniewski
Full-time employees:53
City:Tucson
Address:3430 East Global Loop
IPO:2015-05-06
CIK:0001169987

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

General Outlook

In simple terms, HTG Molecular Diagnostics, Inc. has 2.214 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.184% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.946%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.020%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -1.313% return, is a testament to HTG Molecular Diagnostics, Inc.'s adeptness in optimizing resource deployment. HTG Molecular Diagnostics, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -6.048%. Furthermore, the proficiency of HTG Molecular Diagnostics, Inc. in capital utilization is underscored by a remarkable -3.230% return on capital employed.

Stock Prices

HTG Molecular Diagnostics, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.19, while its low point bottomed out at $2.07. This variance in figures offers investors a lucid insight into the roller-coaster ride that is HTG Molecular Diagnostics, Inc.'s stock market.

Liquidity Ratios

Analyzing HTGM liquidity ratios reveals its financial health of the firm. The current ratio of 140.07% gauges short-term asset coverage for liabilities. The quick ratio (117.32%) assesses immediate liquidity, while the cash ratio (45.68%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio140.07%
Quick Ratio117.32%
Cash Ratio45.68%

Profitability Ratios

HTGM profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -301.86% underscores its earnings before tax deductions. The effective tax rate stands at -0.05%, revealing its tax efficiency. The net income per EBT, 100.05%, and the EBT per EBIT, 102.48%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -294.56%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-301.86%
Effective Tax Rate-0.05%
Net Income per EBT100.05%
EBT per EBIT102.48%
EBIT per Revenue-294.56%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.40, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding117
Days of Inventory Outstanding62
Operating Cycle149.54
Days of Payables Outstanding104
Cash Conversion Cycle46
Receivables Turnover4.17
Payables Turnover3.51
Inventory Turnover5.88
Fixed Asset Turnover3.32
Asset Turnover0.43

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -4.96, and free cash flow per share, -4.97, depict cash generation on a per-share basis. The cash per share value, 2.96, showcases liquidity position. Lastly, the operating cash flow sales ratio, -2.33, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-4.96
Free Cash Flow per Share-4.97
Cash per Share2.96
Operating Cash Flow Sales Ratio-2.33
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-2.76
Short Term Coverage Ratio-3.09
Capital Expenditure Coverage Ratio-773.18
Dividend Paid and Capex Coverage Ratio-773.18

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 36.64%, highlights its total liabilities relative to assets. With a debt-equity ratio of 8.39, we discern the balance between debt and equity financing. The long-term debt to capitalization, 47.14%, and total debt to capitalization, 89.35%, ratios shed light on its capital structure. An interest coverage of -27.42 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio36.64%
Debt Equity Ratio8.39
Long Term Debt to Capitalization47.14%
Total Debt to Capitalization89.35%
Interest Coverage-27.42
Cash Flow to Debt Ratio-2.76
Company Equity Multiplier22.90

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 7.16, provides a glimpse into top-line earnings distributed across each share. Net income per share, -24.28, reflects the portion of profit attributed to each share. The book value per share, 6.06, represents the net asset value distributed per share, while the tangible book value per share, 6.06, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share7.16
Net Income Per Share-24.28
Book Value Per Share6.06
Tangible Book Value Per Share6.06
Shareholders Equity Per Share6.06
Interest Debt Per Share6.40
Capex Per Share-0.03

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -3,828,665.84, captures the company's total value, considering both debt and equity. Income quality, 0.85, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value-3,828,665.84
Income Quality0.85
Research and Development to Revenue106.53%
Capex to Operating Cash Flow0.13%
Capex to Revenue-0.36%
Capex to Depreciation-3.92%
Stock-Based Compensation to Revenue12.79%
Graham Number57.56
Return on Tangible Assets-121.47%
Graham Net Net1.51
Working Capital7,380,694
Tangible Asset Value5,391,697
Net Current Asset Value3,265,493
Invested Capital1
Average Receivables1,757,080.5
Average Payables1,403,444.5
Average Inventory1,448,540.5
Days Sales Outstanding82
Days Payables Outstanding92
Days of Inventory On Hand73
ROIC-185.29%
ROE-4.01%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.24, and the price to book ratio, 2.24, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.23, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.10, and price to operating cash flows, -0.10, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.24
Price to Book Ratio2.24
Price to Sales Ratio0.23
Price Cash Flow Ratio-0.10
Enterprise Value Multiple-0.01
Price Fair Value2.24
Price to Operating Cash Flow Ratio-0.10
Price to Free Cash Flows Ratio-0.10
Price to Tangible Book Ratio0.66
Enterprise Value to Sales-0.60
Enterprise Value Over EBITDA0.19
EV to Operating Cash Flow0.21
Earnings Yield-608.60%
Free Cash Flow Yield-519.44%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of HTG Molecular Diagnostics, Inc. (HTGM) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.075 in 2024.

What is the ticker symbol of HTG Molecular Diagnostics, Inc. stock?

The ticker symbol of HTG Molecular Diagnostics, Inc. stock is HTGM.

What is company IPO date?

IPO date of HTG Molecular Diagnostics, Inc. is 2015-05-06.

What is company current share price?

Current share price is 0.480 USD.

What is stock market cap today?

The market cap of stock today is 1062830.000.

What is PEG ratio in 2024?

The current -0.001 is -0.001 in 2024.

What is the number of employees in 2024?

In 2024 the company has 53.